---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-025697"
form_type: "8-K"
ticker: "OKUR"
cik: "0001637715"
company_name: "OnKure Therapeutics, Inc."
filed_at: "2022-02-02T23:59:59+00:00"
generated_at: "2026-06-27T12:22:25.534495+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Reneo Pharmaceuticals CFO Vineet R. Jindal resigns, effective March 31, 2022

## Summary
- CFO Vineet R. Jindal notified resignation on Jan 28, 2022; effective March 31, 2022.
- Separation agreement includes 9 months base salary severance ($385k/year), 12 months COBRA.
- Equity vesting accelerated by 12 months; consulting engagement offered post-separation at $375/hour for 12 months.
- No replacement CFO named; Jindal to continue service until separation date.

## SEC filing metadata
- accession: 0001193125-22-025697
- form_type: 8-K
- ticker: OKUR
- cik: 0001637715
- company_name: OnKure Therapeutics, Inc.
- filed_at: 2022-02-02T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1637715/000119312522025697/0001193125-22-025697-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1637715/000119312522025697/d304619d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-025697
- JSON: https://secwatch.observer/filing/0001193125-22-025697.json
- Plain text: https://secwatch.observer/filing/0001193125-22-025697.txt

## Key facts
- Executive change
  Vineet R. Jindal resigned as Chief Financial Officer at OnKure Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On January 28, 2022, Vineet R. Jindal notified Reneo Pharmaceuticals, Inc. (the “Company”) of his intention to resign from his position as the Company’s Chief Financial Officer, effective as of March 31, 2022 (the “Separation Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1637715/000119312522025697/0001193125-22-025697-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.